UBS Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.2M | Buy |
|
|||||
|
2025
Q1 | $223K | Buy |
|
|||||
|
2024
Q4 | $285K | Buy |
|
|||||
|
2024
Q3 | $146K | Buy |
|
|||||
|
2024
Q2 | $71.3K | Buy |
|
|||||
|
2024
Q1 | $2.98K | Sell |
|
|||||
|
2023
Q4 | $139K | Buy |
|
|||||
|
2023
Q3 | $29.1K | Buy |
|
|||||
|
2023
Q2 | $5.67K | Sell |
|
|||||
|
2023
Q1 | $7.74K | Sell |
|
|||||
|
2022
Q4 | $25.8K | Sell |
|
|||||
|
2022
Q3 | $48K | Buy |
|
|||||
|
2022
Q2 | $47K | Sell |
|
|||||
|
2022
Q1 | $101K | Sell |
|
|||||
|
2021
Q4 | $267K | Sell |
|
|||||
|
2021
Q3 | $562K | Sell |
|
|||||
|
2021
Q2 | $2.47M | Buy |
|
|||||
|
2021
Q1 | $1.76M | Sell |
|
|||||
|
2020
Q4 | $2.1M | Buy |
|
|||||
|
2020
Q3 | $2.04M | Buy |
|
|||||
|
2020
Q2 | $658K | Sell |
|
|||||
|
2020
Q1 | $1.5M | Sell |
|
|||||
|
2019
Q4 | $5.4M | Buy |
|
|||||
|
2019
Q3 | $3.3M | Buy |
|
|||||
|
2019
Q2 | $3.08M | Sell |
|
|||||
|
2019
Q1 | $3.2M | Buy |
|
|||||
|
2018
Q4 | $2.16M | Sell |
|
|||||
|
2018
Q3 | $6.76M | Buy |
|
|||||
|
2018
Q2 | $4.62M | Sell |
|
|||||
|
2018
Q1 | $19.4M | Buy |
|
|||||
|
2017
Q4 | $1.98M | Sell |
|
|||||
|
2017
Q3 | $867K | Sell |
|
|||||
|
2017
Q2 | $958K | Buy |
|
|||||
|
2017
Q1 | $586K | Buy |
|
|||||
|
2016
Q4 | $280K | Buy |
|
|||||
|
2016
Q3 | $19K | Sell |
|
|||||
|
2016
Q2 | $50K | Sell |
|
|||||
|
2016
Q1 | $60K | Buy |
|
|||||
|
2015
Q4 | $72K | Buy |
|
|||||
|
2015
Q3 | $45K | Sell |
|
|||||
|
2015
Q2 | $273K | Sell |
|
|||||
|
2015
Q1 | $270K | Buy |
|
|||||
|
2014
Q4 | $54K | Buy |
|